CartiHeal Agili-C Granted Breakthrough Device Designation

CartiHeal Agili-C

FDA granted Breakthrough Device Designation for CartiHeal's Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints.

The program is intended to help patients receive more timely access to these medical devices by expediting their development, assessment and review by FDA.

A pivotal...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0